Genomic features of renal cell carcinoma with venous tumor thrombus

Abstract A venous tumor thrombus (VTT) is a potentially lethal complication of renal cell carcinoma (RCC) but virtually nothing is known about the underlying natural history. Based on our observation that venous thrombi contain significant numbers of viable tumor cells, we applied multiregion whole...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, Cathleen Nientiedt, Martina Heller, Laura Van Coile, Yanis Tolstov, Lukas Trennheuser, Kathrin Wieczorek, Carine Pecqueux, Claudia Gasch, Timur Kuru, Joanne Nyarangi-Dix, Gencay Hatiboglu, Dogu Teber, Sven Perner, Albrecht Stenzinger, Wilfried Roth, Boris Hadaschik, Sascha Pahernik, Dirk Jäger, Carsten Grüllich, Anette Duensing, Roland Eils, Matthias Schlesner, Holger Sültmann, Markus Hohenfellner, Stefan Duensing
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fdc0109087c648f893b957962fedc3ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fdc0109087c648f893b957962fedc3ad
record_format dspace
spelling oai:doaj.org-article:fdc0109087c648f893b957962fedc3ad2021-12-02T15:07:48ZGenomic features of renal cell carcinoma with venous tumor thrombus10.1038/s41598-018-25544-z2045-2322https://doaj.org/article/fdc0109087c648f893b957962fedc3ad2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25544-zhttps://doaj.org/toc/2045-2322Abstract A venous tumor thrombus (VTT) is a potentially lethal complication of renal cell carcinoma (RCC) but virtually nothing is known about the underlying natural history. Based on our observation that venous thrombi contain significant numbers of viable tumor cells, we applied multiregion whole exome sequencing to a total of 37 primary tumor and VTT samples including normal tissue specimens from five consecutive patients. Our findings demonstrate mutational heterogeneity between primary tumor and VTT with 106 of 483 genes (22%) harboring functional SNVs and/or indels altered in either primary tumor or thrombus. Reconstruction of the clonal phylogeny showed clustering of tumor samples and VTT samples, respectively, in the majority of tumors. However, no new subclones were detected suggesting that pre-existing subclones of the primary tumor drive VTT formation. Importantly, we found several lines of evidence for “BRCAness” in a subset of tumors. These included mutations in genes that confer “BRCAness”, a mutational signature and an increase of small indels. Re-analysis of SNV calls from the TCGA KIRC-US cohort confirmed a high frequency of the “BRCAness” mutational signature AC3 in clear cell RCC. Our findings warrant further pre-clinical experiments and may lead to novel personalized therapies for RCC patients.Gregor WarsowDaniel HübschmannKortine KleinheinzCathleen NientiedtMartina HellerLaura Van CoileYanis TolstovLukas TrennheuserKathrin WieczorekCarine PecqueuxClaudia GaschTimur KuruJoanne Nyarangi-DixGencay HatibogluDogu TeberSven PernerAlbrecht StenzingerWilfried RothBoris HadaschikSascha PahernikDirk JägerCarsten GrüllichAnette DuensingRoland EilsMatthias SchlesnerHolger SültmannMarkus HohenfellnerStefan DuensingNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gregor Warsow
Daniel Hübschmann
Kortine Kleinheinz
Cathleen Nientiedt
Martina Heller
Laura Van Coile
Yanis Tolstov
Lukas Trennheuser
Kathrin Wieczorek
Carine Pecqueux
Claudia Gasch
Timur Kuru
Joanne Nyarangi-Dix
Gencay Hatiboglu
Dogu Teber
Sven Perner
Albrecht Stenzinger
Wilfried Roth
Boris Hadaschik
Sascha Pahernik
Dirk Jäger
Carsten Grüllich
Anette Duensing
Roland Eils
Matthias Schlesner
Holger Sültmann
Markus Hohenfellner
Stefan Duensing
Genomic features of renal cell carcinoma with venous tumor thrombus
description Abstract A venous tumor thrombus (VTT) is a potentially lethal complication of renal cell carcinoma (RCC) but virtually nothing is known about the underlying natural history. Based on our observation that venous thrombi contain significant numbers of viable tumor cells, we applied multiregion whole exome sequencing to a total of 37 primary tumor and VTT samples including normal tissue specimens from five consecutive patients. Our findings demonstrate mutational heterogeneity between primary tumor and VTT with 106 of 483 genes (22%) harboring functional SNVs and/or indels altered in either primary tumor or thrombus. Reconstruction of the clonal phylogeny showed clustering of tumor samples and VTT samples, respectively, in the majority of tumors. However, no new subclones were detected suggesting that pre-existing subclones of the primary tumor drive VTT formation. Importantly, we found several lines of evidence for “BRCAness” in a subset of tumors. These included mutations in genes that confer “BRCAness”, a mutational signature and an increase of small indels. Re-analysis of SNV calls from the TCGA KIRC-US cohort confirmed a high frequency of the “BRCAness” mutational signature AC3 in clear cell RCC. Our findings warrant further pre-clinical experiments and may lead to novel personalized therapies for RCC patients.
format article
author Gregor Warsow
Daniel Hübschmann
Kortine Kleinheinz
Cathleen Nientiedt
Martina Heller
Laura Van Coile
Yanis Tolstov
Lukas Trennheuser
Kathrin Wieczorek
Carine Pecqueux
Claudia Gasch
Timur Kuru
Joanne Nyarangi-Dix
Gencay Hatiboglu
Dogu Teber
Sven Perner
Albrecht Stenzinger
Wilfried Roth
Boris Hadaschik
Sascha Pahernik
Dirk Jäger
Carsten Grüllich
Anette Duensing
Roland Eils
Matthias Schlesner
Holger Sültmann
Markus Hohenfellner
Stefan Duensing
author_facet Gregor Warsow
Daniel Hübschmann
Kortine Kleinheinz
Cathleen Nientiedt
Martina Heller
Laura Van Coile
Yanis Tolstov
Lukas Trennheuser
Kathrin Wieczorek
Carine Pecqueux
Claudia Gasch
Timur Kuru
Joanne Nyarangi-Dix
Gencay Hatiboglu
Dogu Teber
Sven Perner
Albrecht Stenzinger
Wilfried Roth
Boris Hadaschik
Sascha Pahernik
Dirk Jäger
Carsten Grüllich
Anette Duensing
Roland Eils
Matthias Schlesner
Holger Sültmann
Markus Hohenfellner
Stefan Duensing
author_sort Gregor Warsow
title Genomic features of renal cell carcinoma with venous tumor thrombus
title_short Genomic features of renal cell carcinoma with venous tumor thrombus
title_full Genomic features of renal cell carcinoma with venous tumor thrombus
title_fullStr Genomic features of renal cell carcinoma with venous tumor thrombus
title_full_unstemmed Genomic features of renal cell carcinoma with venous tumor thrombus
title_sort genomic features of renal cell carcinoma with venous tumor thrombus
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/fdc0109087c648f893b957962fedc3ad
work_keys_str_mv AT gregorwarsow genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT danielhubschmann genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT kortinekleinheinz genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT cathleennientiedt genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT martinaheller genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT lauravancoile genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT yanistolstov genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT lukastrennheuser genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT kathrinwieczorek genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT carinepecqueux genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT claudiagasch genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT timurkuru genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT joannenyarangidix genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT gencayhatiboglu genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT doguteber genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT svenperner genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT albrechtstenzinger genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT wilfriedroth genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT borishadaschik genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT saschapahernik genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT dirkjager genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT carstengrullich genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT anetteduensing genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT rolandeils genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT matthiasschlesner genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT holgersultmann genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT markushohenfellner genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
AT stefanduensing genomicfeaturesofrenalcellcarcinomawithvenoustumorthrombus
_version_ 1718388427249942528